Simran Bindu Singh, MD
Psychiatry · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 3 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
9 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Singh’s office at (650) 691-4828 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
9 of 9 plans
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A64299 · Current
Licensed to practise in California · since 1998 · expires 2028-01-31 · Maharshi Dayanand University P.T. Bhagwat Dayal Sharma Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$46,872
Medicare paid this office $46,872 for 41 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $32,909 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,333 | $155 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $2,870 | $56 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,813 | $104 |
Who their Medicare patients are
41 Original Medicare patients in 2024. Average age 64 · Under 65 37% · Also on Medicaid 46% · Health risk score 1.40. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 73% · Diabetes 34%.
The office billed $206,425, Medicare allowed $58,911 and paid $46,872; for 463 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 41 | 463 | 64 | 1.40 | $206,425 | $46,872 |
| 2023 | 40 | 544 | 62 | 1.86 | $174,255 | $55,788 |
| 2022 | 62 | 398 | 66 | 1.61 | $119,570 | $37,268 |
| 2021 | 55 | 597 | 62 | 1.35 | $175,455 | $58,190 |
| 2020 | 39 | 315 | 57 | 1.26 | $132,304 | $30,797 |
| 2019 | 58 | 403 | 59 | 1.59 | $157,324 | $36,376 |
| 2018 | 67 | 324 | 57 | 1.61 | $166,242 | $31,375 |
| 2017 | 76 | 432 | 59 | 1.59 | $168,260 | $39,003 |
| 2016 | 72 | 262 | 56 | 1.29 | $161,620 | $25,673 |
| 2015 | 126 | 440 | 68 | 1.04 | $139,331 | $32,486 |
| 2014 | 140 | 386 | 68 | 1.18 | $89,174 | $29,436 |
| 2013 | 34 | 41 | 69 | 1.42 | $12,562 | $3,909 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $37,394 | $107 |
| Return visit (30+ min) | 15 | $5,649 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $5,626 | $156 |
| Family psychotherapy with patient, 50 minutes | 14 | $2,790 | $87 |
| Psychotherapy with evaluation and management visit, 30 minutes | 14 | $2,290 | $53 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $20,790 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,650 | $174 |
| Psychiatric diagnostic evaluation with medical services | 22 | $3,338 | $145 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $3,299 | $56 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,453 | $97 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $35,706 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $7,894 | $179 |
| Return visit (30+ min) | 15 | $6,902 | $92 |
| Psychotherapy with evaluation and management visit, 30 minutes | 25 | $3,755 | $57 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,485 | $99 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $22,498 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,155 | $186 |
| Psychiatric diagnostic evaluation with medical services | 15 | $1,784 | $119 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $1,171 | $59 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $21,381 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,160 | $181 |
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $2,337 | $57 |
| Psychiatric diagnostic evaluation with medical services | 22 | $2,297 | $104 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $16,141 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,731 | $169 |
| Psychiatric diagnostic evaluation with medical services | 35 | $4,209 | $114 |
| Family psychotherapy with patient, 50 minutes | 11 | $2,329 | $90 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $22,525 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,920 | $174 |
| Psychotherapy with evaluation and management visit, 30 minutes | 21 | $3,223 | $55 |
| Psychiatric diagnostic evaluation with medical services | 29 | $3,058 | $102 |
| Return visit (30+ min) | 12 | $2,168 | $68 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $16,190 | $93 |
| Psychiatric diagnostic evaluation with medical services | 34 | $3,919 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,115 | $173 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $689 | $53 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $8,599 | $93 |
| Return visit (30+ min) | 42 | $6,999 | $96 |
| Short return visit (20+ min) | 48 | $5,487 | $60 |
| Psychiatric diagnostic evaluation with medical services | 42 | $4,607 | $110 |
| Group psychotherapy | 28 | $2,006 | $21 |
| Psychiatric diagnostic evaluation with medical services | 18 | $1,999 | $111 |
2014: 3 services
| Psychiatric diagnostic evaluation with medical services | 107 | $12,424 | $114 |
| Return visit (30+ min) | 51 | $8,611 | $95 |
| Short return visit (20+ min) | 54 | $4,992 | $67 |
2013: 1 service
| Psychiatric diagnostic evaluation with medical services | 17 | $1,823 | $107 |
Medicaid work
$0 in 2018
Medicaid paid $0 for 21 billed services this clinician did in 2018, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Family psychotherapy (conjoint psychotherapy) (with patient present), 50 minutes | 21 | $0 |
| 2018 | 21 | 1 | 21 | $0 |
Drugs they prescribed that Part D paid
$10,472
Pharmacies billed $10,472 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 368) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
350 generic and fewer than 11 brand-name prescriptions · $10,472 in drug cost · 71 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Divalproex | 39 | $419 | $11 |
| Haloperidol | 21 | $272 | $13 |
| Olanzapine | 13 | $240 | $18 |
| Lithium Carbonate | 24 | $240 | $10 |
| Quetiapine | 19 | $238 | $13 |
See all 10 drugs
| Divalproex | 39 | $419 | $11 |
| Haloperidol | 21 | $272 | $13 |
| Olanzapine | 13 | $240 | $18 |
| Lithium Carbonate | 24 | $240 | $10 |
| Quetiapine | 19 | $238 | $13 |
| Risperidone | 33 | $192 | $6 |
| Clozapine | 21 | $180 | $9 |
| Hydroxyzine | 16 | $140 | $9 |
| Benztropine Mesylate | 16 | $74 | $5 |
| Gabapentin | 15 | $68 | $5 |
Year by year
| 2024 | 368 | 45 | 0% (0) | None | $10,472 |
| 2023 | 361 | 26 | 0% (0) | 4% | $6,034 |
| 2022 | 155 | 28 | 0% (0) | None | $3,596 |
| 2021 | 381 | 47 | None | 9% | $55,493 |
| 2020 | 116 | 24 | 0% (0) | None | $12,166 |
| 2019 | 168 | 26 | 0% (0) | 7% | $7,022 |
| 2018 | 179 | 25 | 0% (0) | None | $3,742 |
| 2017 | 226 | 34 | 0% (0) | None | $18,845 |
| 2016 | 115 | 28 | 0% (0) | None | $8,040 |
| 2015 | 464 | 78 | 0% (0) | None | $21,356 |
| 2014 | 682 | 88 | 0% (0) | 11% | $33,525 |
| 2013 | 503 | 71 | 0% (0) | 17% | $26,807 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Olanzapine | 19 | $827 | $44 |
| Divalproex | 26 | $754 | $29 |
| Risperidone | 44 | $589 | $13 |
| Quetiapine | 28 | $402 | $14 |
| Lamotrigine | 24 | $225 | $9 |
| Gabapentin | 17 | $172 | $10 |
| Lithium Carbonate | 16 | $115 | $7 |
| Buspirone | 14 | $109 | $8 |
| Trazodone | 12 | $69 | $6 |
| Hydroxyzine | 14 | $66 | $5 |
2022: 3 drugs
| Gabapentin | 18 | $104 | $6 |
| Trazodone | 15 | $88 | $6 |
| Risperidone | 22 | $84 | $4 |
2021: 12 drugs
| Invega Sustenna | 13 | $33,440 | $2,572 |
| Quetiapine | 15 | $685 | $46 |
| Duloxetine | 13 | $530 | $41 |
| Olanzapine | 25 | $383 | $15 |
| Risperidone | 48 | $336 | $7 |
| Haloperidol | 15 | $255 | $17 |
| Lithium Carbonate | 31 | $233 | $8 |
| Gabapentin | 20 | $228 | $11 |
| Trazodone | 16 | $206 | $13 |
| Benztropine Mesylate | 12 | $147 | $12 |
| Lamotrigine | 17 | $122 | $7 |
| Hydroxyzine | 13 | $114 | $9 |
2020: 2 drugs
| Olanzapine | 12 | $124 | $10 |
| Risperidone | 11 | $63 | $6 |
2019: 3 drugs
| Olanzapine | 13 | $178 | $14 |
| Divalproex | 13 | $67 | $5 |
| Sertraline | 12 | $59 | $5 |
2018: 6 drugs
| Divalproex | 18 | $353 | $20 |
| Trazodone | 18 | $156 | $9 |
| Lithium Carbonate | 13 | $130 | $10 |
| Quetiapine | 15 | $129 | $9 |
| Risperidone | 12 | $106 | $9 |
| Sertraline | 17 | $63 | $4 |
2017: 6 drugs
| Aripiprazole | 13 | $2,354 | $181 |
| Clonazepam | 12 | $337 | $28 |
| Haloperidol | 12 | $166 | $14 |
| Quetiapine | 20 | $118 | $6 |
| Risperidone | 17 | $106 | $6 |
| Sertraline | 11 | $40 | $4 |
2016: 2 drugs
| Divalproex | 11 | $280 | $25 |
| Trazodone | 17 | $241 | $14 |
2015: 15 drugs
| Duloxetine | 25 | $4,169 | $167 |
| Mirtazapine | 37 | $1,122 | $30 |
| Venlafaxine Hcl Er | 34 | $1,109 | $33 |
| Sertraline | 65 | $737 | $11 |
| Buspirone | 11 | $526 | $48 |
| Risperidone | 18 | $524 | $29 |
| Venlafaxine | 14 | $418 | $30 |
| Bupropion Hcl Sr | 17 | $398 | $23 |
| Gabapentin | 35 | $357 | $10 |
| Trazodone | 38 | $324 | $9 |
| Escitalopram | 25 | $270 | $11 |
| Fluoxetine | 15 | $234 | $16 |
| Quetiapine | 12 | $154 | $13 |
| Clonazepam | 17 | $112 | $7 |
| Lithium Carbonate | 16 | $105 | $7 |
2014: 18 drugs
| Abilify | 12 | $11,794 | $983 |
| Duloxetine | 23 | $4,845 | $211 |
| Namenda | 14 | $3,284 | $235 |
| Venlafaxine Hcl Er | 58 | $2,305 | $40 |
| Bupropion Hcl Sr | 60 | $1,180 | $20 |
| Sertraline | 86 | $1,120 | $13 |
| Quetiapine | 43 | $937 | $22 |
| Mirtazapine | 31 | $793 | $26 |
| Bupropion | 19 | $657 | $35 |
| Gabapentin | 58 | $531 | $9 |
| Buspirone | 17 | $525 | $31 |
| Olanzapine | 23 | $494 | $21 |
| Risperidone | 31 | $452 | $15 |
| Trazodone | 58 | $428 | $7 |
| Paroxetine | 29 | $318 | $11 |
| Fluoxetine | 13 | $181 | $14 |
| Citalopram Hbr | 19 | $157 | $8 |
| Escitalopram | 13 | $104 | $8 |
2013: 16 drugs
| Quetiapine | 40 | $4,087 | $102 |
| Bupropion Hcl Sr | 40 | $1,322 | $33 |
| Citalopram Hbr | 27 | $988 | $37 |
| Gabapentin | 60 | $960 | $16 |
| Buspirone | 16 | $819 | $51 |
| Risperidone | 48 | $793 | $17 |
| Venlafaxine Hcl Er | 19 | $750 | $39 |
| Venlafaxine | 11 | $544 | $49 |
| Trazodone | 36 | $248 | $7 |
| Sertraline | 25 | $231 | $9 |
| Escitalopram | 11 | $230 | $21 |
| Lamotrigine | 12 | $176 | $15 |
| Paroxetine | 15 | $172 | $11 |
| Fluoxetine | 14 | $169 | $12 |
| Mirtazapine | 13 | $136 | $10 |
| Clonazepam | 25 | $111 | $4 |
Money from drug and device companies
$34 in 2024
A payment is not proof that care is biased.
| Abbvie | Vraylar | $34 | 1 payment
|
See the published payment
| Abbvie | Meals · 2024-03-02 | Vraylar | $34 |
Professional record
- NPI
- 1760587836
- Licence
- CA A064299California A64299: Current · expires 2028-01-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A642990
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 2500 Grant Rd, Mountain View, CA, 94040
- NPI first listed
- 2006-09-14
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.